title: [Multicenter observational study of the effect of oxcarbazepine on the general well-being of adults with partial epilepsy].
abstract: OBJECTIVE
  An open label, national, multicenter, observational study had been conducted to evaluate of psychological general well-being in adults with therapy resistant partial epilepsy taking oxcarbazepine in Hungary. The possibility was examined to differentiate the improvement of the psychic well-being caused by the better status of the seizure disorder or caused by the psychopharmacological effect of the oxcarbazepine (in the next: OXC).
  
  
  METHODS
  528 patients were asked to fill the Hungarian validated version of Psychological General Well-Being Schedule (PGWB), English version created by Harold J. Dupuy in 1984, at the baseline visit and after 12- week long duration OXC therapy regim. Finally the data of 332 patients could be evaluated per protocol, biostatistical analysis was carried out.
  
  
  RESULTS
  Based on data of 332 patients (per protocol population) the OXC treatment significantly (p < 0.0001) improved all items of PGWB in clinically well-controlled (responder) epileptic patients and improved affective markers of patients with uncontrolled epilepsy also. In case of patients suffering from uncontrolled epilepsy the increase of psychical wellbeing items score influenced by biological effects were higher than those influenced by external effects.
  
  
  CONCLUSIONS
  It can be stated that the adopted PGWB test battery is reliable quantitative method to examine the psychological well-being of patients suffering from partial epilepsy. It was observed that OXC has significant psychopharmalogical effect besides the well-known anticonvulsive property among large Hungarian population of partial epileptic patiens. In case of OXC therapy the positive psychic effect of the successful anticonvulsive treatment and the stabilization property on the affectivity of epileptic patients significantly separates. The OXC has no indication for the treatment of psychiatric conditions.
authors.affiliation: Egyesátett Szent István Kórház es Szent László Kórház Intézményei, Budapest. attilabalogh@hotmail.com
authors.forename: Attila
authors.initials: A
authors.lastname: Balogh
authors.forename: Annamária
authors.initials: A
authors.lastname: Szentesi
authors.forename: István
authors.initials: I
authors.lastname: Jánosi
mesh_terms: D000328:Adult; D000339:Affect; D000368:Aged; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use*; D001007:Anxiety / Q000175:diagnosis; D002220:Carbamazepine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004828:Epilepsies, Partial / Q000188:drug therapy* / Q000523:psychology*; D005260:Female; D006240:Happiness; D006304:Health Status; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D015994:Incidence; D008297:Male; D008875:Middle Aged; D019370:Observation; D009819:Office Visits; D000078330:Oxcarbazepine; D012640:Seizures / Q000453:epidemiology / Q000517:prevention & control*; D020377:Self Efficacy; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D000078330:Oxcarbazepine